Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-21

Clinical Trial Update: Efficacy and Safety of Dapagliflozin in Children With Proteinuria [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing efficacy and safety of dapagliflozin in children with proteinuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Proteinuria | Phase 4 | Status: COMPLETED